In last trading session, CVS Health Corp (NYSE:CVS) saw 42.18 million shares changing hands with its beta currently measuring 0.53. Company’s recent per share price level of $60.34 trading at -$3.33 or -5.23% at ring of the bell on the day assigns it a market valuation of $75.91B. That closing price of CVS’s stock is at a discount of -37.97% from its 52-week high price of $83.25 and is indicating a premium of 12.55% from its 52-week low price of $52.77. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 12.39 million shares which gives us an average trading volume of 9.66 million if we extend that period to 3-months.
For CVS Health Corp (CVS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.93. Splitting up the data highlights that, out of 20 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 6 suggested the stock as a Hold whereas 14 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 1.7 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CVS Health Corp (NYSE:CVS) trade information
Upright in the red during last session for losing -5.23%, in the last five days CVS remained trading in the red while hitting it’s week-highest on Monday, 10/14/24 when the stock touched $60.34 price level, adding 10.99% to its value on the day. CVS Health Corp’s shares saw a change of -23.58% in year-to-date performance and have moved -9.44% in past 5-day. CVS Health Corp (NYSE:CVS) showed a performance of 3.32% in past 30-days. Number of shares sold short was 19.75 million shares which calculate 2.27 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 112 to the stock, which implies a rise of 46.12% to its current value. Analysts have been projecting 63 as a low price target for the stock while placing it at a high target of 127. It follows that stock’s current price would drop -4.41% in reaching the projected high whereas dropping to the targeted low would mean a loss of -4.41% for stock’s current value.
CVS Health Corp (CVS) estimates and forecasts
Statistics highlight that CVS Health Corp is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -13.49% of value to its shares in past 6 months, showing an annual growth rate of -25.51% while that of industry is -36.80. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 3.20% from the last financial year’s standing.
17 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 92.73B for the same. And 17 analysts are in estimates of company making revenue of 96.85B in the next quarter.
In 2024, company’s earnings growth rate is likely to be around -25.82% while estimates for its earnings growth in next 5 years are of 3.73%.
CVS Dividends
CVS Health Corp is more likely to be releasing its next quarterly report on 2024-Nov-06 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt. With an annual yield of 4.31%, the share has a forward dividend of 2.60 which implies that company’s dividend yield remained growing in trailing twelve months while having a 5 year average dividend yield of 2.93%.
CVS Health Corp (NYSE:CVS)’s Major holders
Insiders are in possession of 0.12% of company’s total shares while institution are holding 83.12 percent of that, with stock having share float percentage of 83.21%. Investors also watch the number of corporate investors in a company very closely, which is 83.12% institutions for CVS Health Corp that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at CVS for having 116.35 million shares of worth $6.87 billion. And as of 2024-06-30, it was holding 9.2341 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 100.15 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.9485 of outstanding shares, having a total worth of $5.91 billion.
